The University of Chicago Header Logo

Connection

Richard A. Larson to Histamine H2 Antagonists

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Histamine H2 Antagonists.
Richard A. Larson
Connection Strength
0.433
Histamine H2 Antagonists
  1. Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia. Cancer Chemother Pharmacol. 2012 Aug; 70(2):345-50.
    View in: PubMed
    Score: 0.433
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.